As of Dec 14
| -0.05 / -2.50%|
The 3 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +156.41% increase from the last price of 1.95.
The current consensus among 4 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.